High overexpression of fatty acid synthase is associated with poor survival in Chinese patients with gastric carcinoma
Open Access
- 27 September 2012
- journal article
- Published by Spandidos Publications in Experimental and Therapeutic Medicine
- Vol. 4 (6) , 999-1004
Abstract
Fatty acid synthase (FAS) is the key enzyme regulating de novo biosynthesis of fatty acids. FAS overexpression has been found in many types of tumors and is associated with poor survival. However, the expression of FAS and its relationship with prognosis in Chinese patients with gastric carcinoma are still unknown. Therefore, in this study, we examined the expression of FAS using tissue microarrays and determined its correlation with clinicopathological characteristics and prognosis of gastric carcinoma in Chinese patients. FAS overexpression was graded as S (T/A) <1, ≥1 to <2, ≥2 to <3 or ≥3 in 35 (38.9%), 20 (22.2%), 9 (10%) and 26 (28.9%) patients, respectively. High FAS overexpression [S (T/A) ≥3] was significantly correlated with poor prognosis (log-rank test, P=0.0078) and with decreased 3-year survival rate (χ2 test, P=0.0023). FAS overexpression was not significantly associated with other clinicopathological characteristics. In conclusion, our results suggest that FAS expression might be a potential prognostic marker for gastric carcinoma in Chinese patients.Keywords
This publication has 29 references indexed in Scilit:
- Fatty Acid Synthase Polymorphisms, Tumor Expression, Body Mass Index, Prostate Cancer Risk, and SurvivalJournal of Clinical Oncology, 2010
- Fatty Acid Synthase As a Potential Therapeutic Target in CancerFuture Oncology, 2010
- High Prevalence of Fatty Acid Synthase Expression in Colorectal Cancers in Middle Eastern Patients and Its Potential Role as a Therapeutic TargetAmerican Journal of Gastroenterology, 2009
- Fatty acid synthase inhibitors: new directions for oncologyExpert Opinion on Investigational Drugs, 2007
- Fatty acid synthase and the lipogenic phenotype in cancer pathogenesisNature Reviews Cancer, 2007
- Fatty Acid Synthase and Cancer: New Application of an Old PathwayCancer Research, 2006
- FAS expression inversely correlates with PTEN level in prostate cancer and a PI 3-kinase inhibitor synergizes with FAS siRNA to induce apoptosisOncogene, 2005
- Pharmacological and small interference RNA‐mediated inhibition of breast cancer‐associated fatty acid synthase (oncogenic antigen‐519) synergistically enhances Taxol (paclitaxel)‐induced cytotoxicityInternational Journal of Cancer, 2005
- Expression of Heart-Type Fatty Acid-Binding Protein in Human Gastric Carcinoma and Its Association with Tumor Aggressiveness, Metastasis and Poor PrognosisPathobiology, 2004
- OA-519 (fatty acid synthase) as an independent predictor of pathologic stage in adenocarcinoma of the prostateUrology, 1995